Indegene Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Indegene Ltd. from all sources in a single place.

Load latest

Indegene Ltd.

13 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors / Analysts .

pdf

Indegene Ltd.

13 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

pdf

Indegene Ltd.

13 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Pursuant to Regulation 32[6] of SEBI [LODR] Regulations, 2015 read with Regulation 41[4] of SEBI [ICDR] Regulations, 2018, Please find attached Monitoring Agency Report for the quarter ended December 31, 2024, issued by Care Edge Ratings.

pdf

Indegene Ltd.

13 Feb 2025

549.45

-0.47%

Corp. Note

Indegene Ltd - 544172 - Integrated Filing (Financial)

BSE India

Revised Integrated Filing [Financial] for the quarter ended 31st December 2024.

pdf

Indegene Ltd.

13 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds …

BSE India

Pursuant to Reg 32 of SEBI[LODR] Regulations, 2015, we hereby attach statement of Deviation/Variation in utilization of funds raised through Public Issue by the company for the quarter ended December 31, 2024

pdf

Indegene Ltd.

11 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Reg 30 of SEBI[LODR] Regulations, 2015, enclosed herewith is a press release dated February 11, 2015, titled ''Everest Group Recognizes Indegene as a Front-Runner in GenAI Life Sciences Market Adoption''.

pdf

Indegene Ltd.

10 Feb 2025

549.45

-0.47%

Corp. Note

Indegene Ltd - 544172 - Integrated Filing (Financial)

BSE India

Integrated Filing (financial) for the quarter ended 31st December 2024

pdf

Indegene Ltd.

06 Feb 2025

549.45

-0.47%

Earnings Call

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI[LODR], Regulation, 2015, please find enclosed the transcript of the conference call for the quarter ended December 31, 2024, conducted after the meeting of the Board of Directors held on January 30, 2025.

pdf

Indegene Ltd.

06 Feb 2025

549.45

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Reg 30 of SEBI[LODR] Regulation, 2015, enclosed herewith is a press release dated FEB 06, 2025, titled ''Indegene Expands Footprint in Europe, Launches New Entity in Spain''.

pdf

Indegene Ltd.

31 Jan 2025

549.45

-0.47%

Earnings Call

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 and 46(2)(o) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Q3FY25 earnings call, conducted on January 31,2025 is attached.